Use of PET/MRI Tracer to Further Understanding of Prostate Cancer Development
NCT02106416 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2017-10-11
Summary
The purpose of this study is to develop a novel technique for integrated PET/MRI tracer kinetic analysis for urologic malignancy.
Conditions
Interventions
- PROCEDURE
-
PET/MRI
Simultaneous PET/MRI (3T system)
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Andrew Rosenkrantz, MD · NYU School of Medicine
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-08-31
- Primary Completion
- 2016-04-30
- Completion
- 2016-04-30
Countries
- United States
Study Locations
More Related Trials
-
Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques
NCT02935816 ·Status: UNKNOWN
-
Magnetic Resonance Imaging to Locate and Characterize Prostate Cancer
NCT00082147 ·Status: COMPLETED ·Phase: NA
-
Novel PET/CT Agents and MRS/MRI in Prostate CA and High Risk Prostate Cancer: An Inter-SPORE Collaboration
NCT00987376 ·Status: COMPLETED ·Phase: PHASE1
-
MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
NCT01464216 ·Status: ACTIVE_NOT_RECRUITING
-
MRI in Clinical Staging and Estimation of Treatment Response in Bladder Cancer
NCT02662166 ·Status: COMPLETED ·Phase: NA
-
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
NCT04692675 ·Status: RECRUITING ·Phase: NA
-
Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer
NCT02420977 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Prostate Cancer Subclinical Metastatic Ablative MR-guided Radiotherapy
NCT03160794 ·Status: RECRUITING ·Phase: NA
-
Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer
NCT00039624 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma
NCT00230386 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)
NCT00890006 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
PSMA-PET/MRI Low- and Intermediate-Risk Prostate Cancer
NCT04243941 ·Status: WITHDRAWN ·Phase: PHASE2
-
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancer
NCT03232164 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study
NCT04176497 ·Status: TERMINATED ·Phase: PHASE2
-
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
NCT03354416 ·Status: RECRUITING
-
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
NCT03173924 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
NCT03976843 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Molecular PET/MR Imaging in Vivo Validation of Biomarker for Human Prostate Cancer
NCT03451812 ·Status: UNKNOWN
-
NEWPROMRI-PATHWAY - A New Prostate Magnetic Resonance Imaging (MRI) Pathway
NCT06672926 ·Status: RECRUITING
-
18F-PSMA PET and MRI in the Primary Staging of Prostate Cancer Patients
NCT05141760 ·Status: COMPLETED ·Phase: PHASE2
-
Intensity Modulated Radiation Therapy for Prostate Cancer
NCT00214422 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
NCT03181867 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Assessment of New Molecular Imaging Strategies for Prostate Cancer
NCT02813226 ·Status: COMPLETED ·Phase: NA
-
Dynamic Whole Body PET/ MRI
NCT04495959 ·Status: WITHDRAWN
-
Study of 18F-DCFPyL, a Second Generation Low-molecular Weight PSMA-based PET Radiotracer, in Patients With Prostate Cancer
NCT02151760 ·Status: COMPLETED ·Phase: PHASE1